2021
DOI: 10.1371/journal.pntd.0009057
|View full text |Cite
|
Sign up to set email alerts
|

Use-case scenarios for an anti-Cryptosporidium therapeutic

Abstract: Cryptosporidium is a widely distributed enteric parasite that has an increasingly appreciated pathogenic role, particularly in pediatric diarrhea. While cryptosporidiosis has likely affected humanity for millennia, its recent “emergence” is largely the result of discoveries made through major epidemiologic studies in the past decade. There is no vaccine, and the only approved medicine, nitazoxanide, has been shown to have efficacy limitations in several patient groups known to be at elevated risk of disease. I… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(34 citation statements)
references
References 109 publications
1
29
0
1
Order By: Relevance
“…Among the opportunistic agents, Cryptosporidium , a protozoan parasite classically associated with AIDS, is the most frequent finding in children with diarrhea. The two species more frequently isolated are C. parvum (mostly subtype IIa), usually considered a zoonotic disease, and C. hominis , almost exclusively transmitted from person-to-person [ 60 , 61 , 62 ].…”
Section: The Spectrum Of Diarrheal Disease In Hivmentioning
confidence: 99%
“…Among the opportunistic agents, Cryptosporidium , a protozoan parasite classically associated with AIDS, is the most frequent finding in children with diarrhea. The two species more frequently isolated are C. parvum (mostly subtype IIa), usually considered a zoonotic disease, and C. hominis , almost exclusively transmitted from person-to-person [ 60 , 61 , 62 ].…”
Section: The Spectrum Of Diarrheal Disease In Hivmentioning
confidence: 99%
“…In neonatal livestock, cryptosporidiosis can cause profuse diarrhoea, weight loss and death [ 11 , 21 , 22 , 23 ], resulting in significant production losses [ 22 , 24 , 25 , 26 ]. The only US Food and Drug Administration approved drug, nitazoxanide, is ineffective in the most affected populations (children and immunocompromised individuals) and there is no FDA-approved vaccine [ 27 , 28 , 29 , 30 ]. In animals, nitazoxanide is also largely ineffective and while Halocur ® (halofuginone lactate) has been licensed in some countries as a prophylactic, its effectiveness is variable and it cannot be given to animals that already have diarrhoea [ 11 , 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…It may be due to the improvement of the sanitation and hygiene system. Empirical use of antiparasitic drugs could be one of the reasons behind the low prevalence of intestinal parasites in our country [115,116]. Failure to detect intestinal protozoan parasites may be due to seasonal variation and the intermittent nature of excretion of this parasite in the stool [47,117].…”
Section: Discussionmentioning
confidence: 99%